Bioxytran, Inc
BIXT· OTC
BIXTBioxytran, Inc
Filed Nov 3, 2023 · 10-Q · 34 days after period end · 0001493152-23-039202
| Metric | Q3 2023 | Q3 2022 | Q3 2021 | Q3 2020 |
|---|---|---|---|---|
| Net Income | -$1.00M | -$123.64K | -$609.68K | -$202.04K |
| EPS Diluted | -$0.01 | $0.00 | $0.00 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bioxytran, Inc · CIK 1445815 · Engraved from SEC EDGAR
ended Sep 30, 2023 · filed Nov 3, 2023 · 34 d after period end
